Lung cancer is the leading cause of cancer death in the United States. Oncologists need to be aware of new treatment options and recommendations so they can implement the best treatment plans and thus improve outcomes for their patients with lung cancer. The 2014 NCCN Congress Series™: Utilizing Guidelines to Customize Patient Care in Non-Small Cell Lung Cancer will discuss the most recent developments in diagnosis and treatment to ensure that members of a multidisciplinary team, including physicians, nurses, pharmacists and other relevant healthcare professionals, have the knowledge and skills necessary to apply the standards of care to their practice and healthcare setting for patients with non-small cell lung cancer.
This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other healthcare professionals who manage patients with non-small cell lung cancer.
New Recommendations for Lung Cancer Screening and Follow-up
Biomarkers and Testing in Lung Cancer
Treatment of Advanced Disease
Saturday, October 25, 2014 7:30 AM - 12:00 PM
Massachusetts General Hospital Cancer CenterO'Keefe Auditorium55 Fruit StreetBoston, Massachusetts 02114
NCCN Meetings Department
NCCN.org – For Clinicians | NCCN.org/patients – For Patients
National Comprehensive Cancer Network | 275 Commerce Drive | Suite 300 | Fort Washington | PA | 19034 | US | 215.690.0300